EA202191927A1 - MODULATORS GPR35 - Google Patents
MODULATORS GPR35Info
- Publication number
- EA202191927A1 EA202191927A1 EA202191927A EA202191927A EA202191927A1 EA 202191927 A1 EA202191927 A1 EA 202191927A1 EA 202191927 A EA202191927 A EA 202191927A EA 202191927 A EA202191927 A EA 202191927A EA 202191927 A1 EA202191927 A1 EA 202191927A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- gpr35
- modulators
- compounds
- present
- describes
- Prior art date
Links
- 102100030279 G-protein coupled receptor 35 Human genes 0.000 title abstract 2
- 101001009545 Homo sapiens G-protein coupled receptor 35 Proteins 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
В настоящем изобретении описаны GPR35 модуляторы и способы применения таких соединений при лечении заболеваний, нарушений или состояний. Также в настоящем изобретении описаны фармацевтические композиции, содержащие такие соединения.The present invention describes GPR35 modulators and methods of using such compounds in the treatment of diseases, disorders or conditions. The present invention also describes pharmaceutical compositions containing such compounds.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962928223P | 2019-10-30 | 2019-10-30 | |
| PCT/US2020/014777 WO2020154492A1 (en) | 2019-01-24 | 2020-01-23 | Gpr35 modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202191927A1 true EA202191927A1 (en) | 2021-12-23 |
Family
ID=80631206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202191927A EA202191927A1 (en) | 2019-10-30 | 2020-01-23 | MODULATORS GPR35 |
Country Status (1)
| Country | Link |
|---|---|
| EA (1) | EA202191927A1 (en) |
-
2020
- 2020-01-23 EA EA202191927A patent/EA202191927A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202192625A1 (en) | PSEUDOKINASE TYK2 LIGANDS | |
| EA201992083A1 (en) | SOMATOSTATIN MODULATORS AND THEIR APPLICATION | |
| EA202092490A1 (en) | METHYL-MODIFYING ENZYMES MODULATORS, COMPOSITIONS AND THEIR APPLICATION | |
| EA202091708A1 (en) | DNA PC INHIBITORS | |
| EA201890725A1 (en) | PHARNESIDE X-RECEPTOR AGONISTS AND THEIR APPLICATION | |
| WO2018069500A3 (en) | ANTI-LAG-3 ANTIBODIES AND COMPOSITIONS | |
| EA201990598A1 (en) | HIGHLY CONCENTRATED LOW VISCOUS DRUGS MASP-2 ANTIBODIES, KITS AND METHODS | |
| EA201991553A1 (en) | (AZA) INDOL-, BENZOTIOPHEN- AND BENZOFURAN-3-SULFONAMIDES | |
| MX2022000712A (en) | Nlrp3 modulators. | |
| EA202091559A1 (en) | METHOD FOR OBTAINING SOMATOSTATIN MODULATORS | |
| CL2022001178A1 (en) | tyk2 pseudokinase ligands | |
| MX2021009555A (en) | Tyk2 pseudokinase ligands. | |
| MA53765B2 (en) | Tubulysines et conjugués protéine-tubulysine | |
| MX2024011254A (en) | Nlrp3 modulators | |
| EA202090414A1 (en) | COMPOUNDS AND THEIR APPLICATION | |
| PH12022552447A1 (en) | Nlrp3 modulators | |
| MX2021013602A (en) | JAK INHIBITORS. | |
| EA201892265A1 (en) | METHODS OF TREATMENT OF OPHTHALMIC DISEASES | |
| EA201890460A1 (en) | COMPOSITIONS AND METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISORDERS | |
| EA201792571A1 (en) | THERAPEUTIC APPLICATION OF L-4-CHLOROKINURENIN | |
| BR112021014566A2 (en) | gpr35 modulators | |
| EA201991898A1 (en) | DOUBLE MAGL AND FAAH INHIBITORS | |
| EA202191115A1 (en) | NEW PYRIDAZINES | |
| EA202190766A1 (en) | IMMUNOMODULATORS, THEIR COMPOSITIONS AND METHODS OF APPLICATION | |
| EA202092051A1 (en) | SPIROCYCLIC MODULATORS ROR-GAMMA |